U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953934) titled 'A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants' on April 24.

Brief Summary: The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.

Study Start Date: May 12

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-932

Oral Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....